An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels

Erstveröffentlichung
2010Authors
Petzold, Axel
Chapman, Miles D.
Schraen, Susanna
Verwey, Nicolaas A.
Pasquier, Florence
Beitrag zu einer Konferenz
Published in
Experimental Neurology ; 223 (2010), 2, SI. - S. 432-438. - ISSN 0014-4886. - eISSN 1090-2430
Link to publication
https://dx.doi.org/10.1016/j.expneurol.2009.11.010Institutions
UKU. Klinik für NeurologieBezirkskrankenhaus Günzburg
Sonderforschungsbereich SFB 1279 Exploting the Human Peptidome for Novel Antimicrobial and Anticancer Agents
Conference
10th International Conference on Alzheimers Disease and Related Disorders, 2006-07-15 - 2006-07-16, Madrid
Subject headings
[Free subject headings]: Cerebrospinal fluid | CSF | tau | Dementia | CEREBROSPINAL-FLUID-TAU | FRONTOTEMPORAL LOBAR DEGENERATION | MILD COGNITIVE IMPAIRMENT | BETA-AMYLOID 1-42 | BIOCHEMICAL MARKER | PHOSPHORYLATED-TAU | DIAGNOSTIC MARKER | REFERENCE VALUES | PROTEIN LEVELS[DDC subject group]: DDC 610 / Medicine & health